Deep brain stimulation of subthalamic nucleus for Parkinson's disease

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 7, 2016, Pages

  Motto, Cristina ^a   Tamma, Filippo ^b   Candelise, Livia ^c   Pecoraro, Valentina ^d   Banzi, Rita ^d   Moja, Lorenzo ^e  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b Dipartimento di Scienze Neurologiche ^*  (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; PRIORITY JOURNAL; RETRACTED ARTICLE;

EID: 84978852414     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD004491.pub2     Document Type: Article

References (43)

1. Ahlskog JE, Muenter MD. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Movement disorders 2001;16:448-458.
2. Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP. Pallidal vs Subthalamic Nucleus Deep Brain Stimulation in Parkinson Disease. Arch Neurol 2005;62:554-560.
3. Appleby BS, Duggan PS, Regenberg A, Rabins PV. Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: a meta-analysis of ten years' experience. Movement Disorders 2007;22:1722-1728.
4. Ben-Haim S, Asaad WF, Gale JT, Eskandar EN. Risk factors for hemorrhage during microelectrode-guided deep brain stimulation and the introduction of an improved microelectrode design. Neurosurgery 2009;64:754.
5. Benabid AL, Chabardes S, Mitrofanis J, Pollak P. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurology 2009;8:67-81.
6. Benazzouz A, Piallat B, Pollak P. Responses of substantia nigra pars reticulata and globus pallidus complex to high frequency stimulation of the subthalamic nucleus in rats: electrophysiological data. Neurosci Lett 1995;189:77-80.
7. Binder DK, Rau GM, Starr Pa. Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders. Neurosurgery 2005;56:722.
8. Bronstein JM, Tagliati M, Alterman RL, Lozano AM, Volkmann J, Stefani A, Horak FB, Okun MS, Foote KD, Krack P, Pahwa R, Henderson JM, Hariz MI, Bakay RA, Rezai A, Marks WJ, Moro E, Vitek JL, Weaver FM, Gross RE, DeLong MR. Deep Brain Stimulation for Parkinson Disease. Arch Neurol 2011;68:165-171.
9. Burchiel KJ, Anderson VC, Favre J, Hammerstad JP. Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: results of a randomized, blinded pilot study. Neurosurgery 1999;45:1375-1384.
10. Clatterbuk RE, Lee JI, Lenz FA. Movement disorders surgery: lesions or stimulation. Prog Neurol Surg 2000;15:227-35.
11. DBS Parkinson's disease study group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2002;345:956.
12. The Deep-Brain Stimulation for Parkinson's Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001;345:956-63.
13. Duvoisin R, Sage J. Lippincott Williams and Wilkins. Parkinson's Disease, 2001 .
14. Erba G, Moja L, Beghi E, Messina P, Pupillo E. Barriers toward epilepsy surgery. A survey among practicing neurologists. Epilepsia 2012;53(1):35-43. [PUBMED: 21973118]
15. Erba G, Messina P, Pupillo E, Beghi E. Acceptance of epilepsy surgery in the pediatric age - what the parents think and what the doctors can do. Epilepsy & behavior : E&B 2013;29(1):112-20. [PUBMED: 23939035]
16. Hariz MI. Complications of movement disorder surgery and how to avoid them. Prog Neurol Surg 2000;15:246-65.
17. Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration. Available from www.cochrane-handbook.org . 2009.
18. Higgins JPT, Deeks JJ, Altman DG on behalf of the Cochrane Statistical Methods Group. Chapter 16: Special issues in statistics. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration. Available from www.cochrane-handbook.org. 2009.
19. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration 2011. Available from www.cochrane-handbook.org., 2011.
20. Jankovic J. Complications and limitations of drug therapy for Parkinson's disease. Neurology 2000;55(suppl. 6):S2-6.
21. Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons K, Pahwa R, Lang AE, Deuschl G. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Movement Disorders 2006;21:S290-S304.
22. Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, Koudsie A, Limousin PD, Benazzouz A, LeBas JF, Benabid AL, Pollak P. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. NEJM 2003;349(20):1925-34.
23. Kumar R, Lozano AM, Kim YJ, Hutchinson WD, Sime E, Halket E, Lang AE. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology 1998;51:850-55.
24. Lang AE, Widner H. Deep brain stimulation for Parkinson's disease: patient selection and evaluation. Movement Disorders 2002;17(suppl. 3):S94-101.
25. Limousin P, Krack P, Pollak P, Benauzzouz A, Ardouin C, Hoffmann D, Benabid AL. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998;339:1105-11.
26. Limousin-Dowsey P, Pollak P, Van Blercom N, Krack P, Benazzouz A, Benabid AL. Thalamic, subthalamic nucleus and internal pallidum stimulation in Parkinson's disease. J Neurol 1999;246(suppl. 2):II/42-45.
27. Moro E, Lozano AM, Pollak P, Agid Y, Rehncrona S, Volkmann J, Kulisevsky J, Obeso JA, Albanese A, Hariz MI, Quinn NP, Speelman JD, Benabid AL, Fraix V, Mendes A, Welter ML, Houeto jl, Cornu P, Dormont D, Tornqvist AL, Ekberg R, Schnitzler A, Timmermann L, Wojteck L, Gironell A, Rodriguez-Oroz MC, Guridi J, Bentivoglio AR, Contarino MF, Romito L, Scerrati M, Janssens M, Lang AE. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's Disease. Movement Disorders 2010;25(5):578-586.
28. Nutt JC. Levodopa induced dyskinesias. Neurology 1990;40:340-5.
29. Obeso JA, Guridi J, DeLong MR. Surgery for Parkinson's disease. J Neurol Neurosurg Psychiatry 1997;62:2-8.
30. Parsons TD, Rogers SA, Braaten AJ, Woods SP, Tröster AI. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis. Lancet Neurology 2006;5:578-88.
31. Ramaker C, Marinus J, Stiggelbout AM, et al. Systematic evaluationof rating scales for impairment and disability in Parkinson'sdisease: a systematic review.. Mov Disord 2002;17:867.
32. Rascol O, Goetz C, Koller W, Poewe W, Sampaio C. Treatment interventions for Parkinson's disease: an evidence based assessment. The Lancet 2002;359:1589-98.
33. Schrag A, Sampaio C, Counsell N, Poewe W. Minimal clinically important change on the unified Parkinson's disease rating scale. Movement Disorder 2006;21:1200-7.
34. Temel Y, et al. Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review. Parkinsonism Relat Disord 2006;12(5):265-72.
35. U.S. Department of Health and Human Services. FDA approves implanted brain stimulator to control tremors. Retrieved October 18, 2006.
36. Volkmann J, Albanese A, Kulisevsky J, Tornqvist AL, Houeto JL, Pidoux B, Bonnet AM, Mendes A, Benabid AL, Fraix V, Van Blercom N, Xie J, Obeso J, Rodriguez-Oroz MC, Guridi J, Schnitzler A, Timmermann L, Gironell AA, Molet J, Pascual-Sedano B, Rehncrona S, Moro E, Lang AC, Lozano AM, Bentivoglio AR, Scerrati M, Contarino MF, Romito L, Janssens M, Agid Y. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease. Mov Disord 2009;24(8):1154-61.
37. Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ Jr, Rothlind J, Sagher O, Reda D, Moy CS, Pahwa S, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein J, Stoner G, Heemskerk J, Huang GD, for the CSP 468 Study Group. Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson Disease: A Randomized Controlled Trial. 2009; Vol. 301:63-73.
38. Weaver F, Follett KA, Stern M, Luo P, Harris CL, Hur K, Marks WJ, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai E, Duda JE, Holloway K, Samii A, Horn S, Bronstein JM, Stoner G, Starr PA, Simpson R, Baltuch G, De Salles A, Huang GD, Reda DJ. Randomized trial of deep brain stimulationfor Parkinson disease.. Neurology 2012;79:55-65.
39. Wichmann T, Bergamn H, DeLong MR. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism. J Neurophysiol 1994;72:521-30.
40. Williamson PR, Gamble C, Altman DG, Hutton JL. Outcome selection bias in meta-analysis. Stat Methods Med Res 2005;14(515-24).
41. Xiaowu H, Xiufeng J, Xiaoping Z, Bin H, Laixing W, Yiqun C. Risks of intracranial hemorrhage in patients with Parkinson's disease receiving deep brain stimulation and ablation. Parkinsonism Relat Disord 2010;16:96-100.
42. Zahodne LB, Okun MS, Foote KD, Fernandez HH, Rodriguez RL, Wu SS, Kirsch-Darrow L, Jacobson CE 4th, Rosado C, Bowers D. Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus.. J Neurol. 2009;256(8):1321-9.
43. Ahlskog JE, Muenter MD. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Movement Disorders 2001;16:448-458.